ArashMahajerinMD

Physician

Dr. Mahajerin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
101 The City Dr S
Bldg 23
Orange, CA 92868
Phone+1 714-456-8000

Fax+1 714-532-8771

Indiana University School of MedicineFellowship, Pediatric Hematology/Oncology, 2010 - 2013
Indiana University School of MedicineResidency, Pediatrics, 2007 - 2010
Michigan State University College of Human MedicineClass of 2007

PubMed

Clinical and treatment characteristics of infants and toddlers less than 2 years of age with hemophilia.
Jennifer H Han, Brandi Dupervil, Arash Mahajerin, Roshni Kulkarni, Marilyn Manco-Johnson
Blood Advances. 2024-06-11
1 citations
Long-term follow-up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma-derived factor VIII (Koate) that contains ADAMTS13.
Tammuella Chrisentery-Singleton, Lisa N Boggio, Manuel D Carcao, Sami Ibrahimi, Osman Khan
Haemophilia. 2023-11-01
5 citations
Antithrombin Therapy: Current State and Future Outlook.
George M Rodgers, Arash Mahajerin
Clinical and Applied Thrombosis/hemostasis. 2023-10-12

Abstracts/Posters

Assessing Venous Thromboembolism Risk in Critically Ill Children: A Report from the ChildrenÍs Hospital-Acquired Thrombosis (CHAT) Consortium
Arash Mahajerin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Estimating the Burden of Intracranial Hemorrhage in Persons with Hemophilia A using Administrative Claims Data
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Risk Factors for Hospital-Acquired Venous Thromboembolism in Children: Findings from the Children’s Hospital-Acquired Thrombosis (CHAT) Registry
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018